rs1555328087
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PP5_Moderate
The NM_018139.3(DNAAF2):c.484C>T(p.Gln162*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_018139.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 152244Hom.: 0 Cov.: 35 FAILED QC
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1454426Hom.: 0 Cov.: 97 AF XY: 0.00 AC XY: 0AN XY: 723894
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 152244Hom.: 0 Cov.: 35 AF XY: 0.00 AC XY: 0AN XY: 74380
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Pathogenic:1
This sequence change creates a premature translational stop signal (p.Gln162*) in the DNAAF2 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with DNAAF2-related disease. Loss-of-function variants in DNAAF2 are known to be pathogenic (PMID: 19052621). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at